---
phase: 69-script-documentation
plan: 03
subsystem: treatment-analysis
tags: [documentation, clinical-logic, WHY-comments]
dependency_graph:
  requires: [69-02-SUMMARY]
  provides: [treatment-scripts-documented]
  affects: [R/20-29]
tech_stack:
  added: []
  patterns: [5-field-headers, section-navigation, clinical-WHY-comments]
key_files:
  created: []
  modified:
    - R/20_treatment_inventory.R
    - R/21_investigate_unmatched.R
    - R/22_investigate_unmatched_ndc.R
    - R/23_combine_reports.R
    - R/24_treatment_codes_resolved.R
    - R/25_treatment_durations.R
    - R/26_treatment_episodes.R
    - R/27_drug_name_resolution.R
    - R/28_episode_classification.R
    - R/29_first_line_and_death_analysis.R
decisions:
  - id: CLINICAL-WHY-01
    summary: WHY comments explain clinical rationale (90-day gaps, 60-day clean period)
    rationale: Treatment scripts implement complex clinical standards that are not self-evident from code
  - id: PRESERVE-D-REF
    summary: Preserved all existing D-01 through D-13 decision references in R/25
    rationale: R/25 already had excellent traceability; standardized format while keeping existing content
metrics:
  duration_minutes: 60
  completed: 2026-06-02T02:45:59Z
  tasks_completed: 2
  files_modified: 10
  commits: 2
---

# Phase 69 Plan 03: Treatment Analysis Script Documentation

**One-liner:** Full 5-field headers, section navigation, and clinical WHY comments for all treatment analysis scripts (20-29)

## Overview

Documented 10 treatment analysis scripts with standardized headers, numbered section navigation, and clinical WHY comments explaining complex logic (90-day episode gaps, RxNorm API usage, ABVD/BV+AVD regimen detection, 60-day clean period for first-line therapy).

## What Was Done

### Task 1: Scripts 20-24 (Treatment Inventory and Code Resolution)

Applied full documentation standard to:
- **R/20_treatment_inventory.R**: 5-field header, 7 section headers converted, WHY comments for 7-table search and CPT/HCPCS heuristics
- **R/21_investigate_unmatched.R**: 5-field header, WHY comment for NLM HCPCS API usage
- **R/22_investigate_unmatched_ndc.R**: 5-field header, section headers standardized, WHY comment for RxNorm API NDC→ingredient normalization
- **R/23_combine_reports.R**: 5-field header, section headers standardized, WHY comment for report consolidation
- **R/24_treatment_codes_resolved.R**: 5-field header, section headers standardized, WHY comment for per-type file separation

**WHY comments added:**
- **R/20**: WHY 7 PCORnet tables searched (treatment evidence scattered), WHY range heuristics (detect missed codes)
- **R/21**: WHY NLM API (official CMS descriptions, automated bulk lookup)
- **R/22**: WHY RxNorm API (NDC manufacturer-specific → ingredient level normalization)
- **R/23**: WHY combine reports (single deliverable for clinical review)
- **R/24**: WHY separate files per type (different clinical reviewers)

### Task 2: Scripts 25-29 (Treatment Duration, Episodes, First-Line Therapy)

Applied full documentation standard to:
- **R/25_treatment_durations.R**: 5-field header preserving all D-01 through D-13 references, section headers converted from "---" to "----", WHY comments for 90-day gap threshold and 7-table search
- **R/26_treatment_episodes.R**: 5-field header, section headers standardized, WHY comment for historical date flagging
- **R/27_drug_name_resolution.R**: 5-field header, WHY comment for chemotherapy-only resolution
- **R/28_episode_classification.R**: 5-field header, section headers standardized, 3 WHY comments (ENCOUNTERID linkage, 30-day fallback, regimen detection)
- **R/29_first_line_and_death_analysis.R**: 5-field header, section headers standardized, 2 WHY comments (60-day clean period, death validation)

**Critical clinical WHY comments:**
- **R/25**: WHY 90-day gap threshold (clinical standard for oncology treatment cycles), WHY all 7 PCORnet tables (comprehensive treatment detection)
- **R/26**: WHY historical date flagging (data quality filtering without data loss)
- **R/27**: WHY chemotherapy only (other types identified adequately by codes)
- **R/28**: WHY ENCOUNTERID first (most reliable encounter context), WHY 30-day temporal fallback (clinical proximity), WHY specific drug combos (ABVD/BV+AVD/Nivo+AVD fingerprints with dropped-agent tolerance)
- **R/29**: WHY 60-day clean period (standard oncology first-line definition), WHY death date validation (impossible deaths = data quality issues)

## Deviations from Plan

None - plan executed exactly as written.

## Known Stubs

None detected. All scripts are production code with real data processing.

## Commits

| Task | Commit | Message |
|------|--------|---------|
| 1 | `38246ef` | feat(69-03): document treatment inventory and code resolution scripts (20-24) |
| 2 | `102d469` | feat(69-03): document treatment duration and first-line therapy scripts (25-29) |

## Key Technical Details

### Documentation Standard Applied

**5-field header block:**
```r
# Purpose:     <concise one-line description>
# Inputs:      <data sources>
# Outputs:     <file paths>
# Dependencies: <source() chain>
# Requirements: <traceability to phases/requirements>
```

**Section navigation:**
- Format: `# SECTION N: TITLE ----` (4+ trailing dashes for folding)
- Replaces all variants: `# === SECTION ===`, `# --- SECTION ---`, etc.

**WHY comments:**
- Placed after configuration blocks
- Explain clinical rationale (90-day gaps, 60-day clean periods)
- Explain technical choices (RxNorm API for NDC normalization)
- Focus on WHY not WHAT (code is self-documenting for WHAT)

### Clinical Logic Documented

1. **90-day episode gap threshold** (R/25): Clinical standard for oncology treatment cycles. Gaps >90 days = separate episodes (relapse/new line).

2. **ENCOUNTERID linkage → 30-day fallback** (R/28): Primary linkage via encounter context (most reliable), temporal proximity fallback when missing.

3. **ABVD/BV+AVD/Nivo+AVD regimen detection** (R/28): Distinct 4-drug fingerprints. Dropped-agent tolerance (AVD without bleomycin) per RATHL trial standard.

4. **60-day clean period for first-line** (R/29): Standard oncology definition. No prior chemo in 60 days before regimen start = first course (not continuation/relapse).

5. **7-table treatment search** (R/20, R/25): Treatment evidence scattered across PROCEDURES, PRESCRIBING, MED_ADMIN, DIAGNOSIS, ENCOUNTER, DISPENSING, TUMOR_REGISTRY. Comprehensive search maximizes detection.

6. **RxNorm API for NDC resolution** (R/22, R/27): NDC codes are manufacturer-specific (not clinically meaningful). RxNorm normalizes to ingredient level for regimen matching.

## Self-Check: PASSED

**Files created:** None (documentation only)

**Files modified (verified):**
- R/20_treatment_inventory.R: `# Purpose:` found, 7 section headers with `----`
- R/21_investigate_unmatched.R: `# Purpose:` found, section headers standardized
- R/22_investigate_unmatched_ndc.R: `# Purpose:` found, section headers standardized
- R/23_combine_reports.R: `# Purpose:` found, section headers standardized
- R/24_treatment_codes_resolved.R: `# Purpose:` found, section headers standardized
- R/25_treatment_durations.R: `# Purpose:` found, D-01 through D-13 references preserved
- R/26_treatment_episodes.R: `# Purpose:` found, section headers standardized
- R/27_drug_name_resolution.R: `# Purpose:` found, WHY chemotherapy-only comment added
- R/28_episode_classification.R: `# Purpose:` found, 3 WHY comments (ENCOUNTERID, 30-day, regimen)
- R/29_first_line_and_death_analysis.R: `# Purpose:` found, 2 WHY comments (60-day, death)

**Commits verified:**
```bash
$ git log --oneline --grep="69-03"
102d469 feat(69-03): document treatment duration and first-line therapy scripts (25-29)
38246ef feat(69-03): document treatment inventory and code resolution scripts (20-24)
```

**Critical WHY comments verified:**
```bash
$ grep -c "WHY.*90-day" R/25_treatment_durations.R
1
$ grep -c "WHY.*60.*day" R/29_first_line_and_death_analysis.R
1
$ grep -c "WHY.*ENCOUNTERID" R/28_episode_classification.R
2
```

All files exist, commits present, and critical WHY comments verified.
